Secondhand smoke from electronic cigarette resulting in hypersensitivity pneumonitis.
Individual Clinical
Respiratory Toxicity
Secondary & Tertiary Exposure
Galiatsatos (2020)
Passive exposure to nicotine from e-cigarettes
Individual Clinical
Respiratory Toxicity
Secondary & Tertiary
Exposure
Gallart (2016)
Transitions between tobacco products: Correlates of changes in cigarette smoking and e-cigarette use among exclusive adult smokers and dual users in Mexico.
Population Clinical
Likelihood Of Use
Gallegos-Carillo (2022)
Workshop summary: Top concentration for in vitro mammalian cell genotoxicity assays; and report from working group on toxicity measures and top concentration for in vitro cytogenetics assays (chromosome aberrations and micronucleus)
Non-Clinical
Genotoxicity
In Vitro
Galloway (2011)
Electronic cigarette use among Italian smokers: patterns, settings, and adverse events.
Individual Clinical
User Topography
Gallus (2020)
Impact of electronic cigarette and heated tobacco product on conventional smoking: an Italian prospective cohort study conducted during the COVID-19 pandemic.
Population Clinical
Population Health Impact
Gallus (2022)
Electronic Cigarette Use in 12 European Countries: Results From the TackSHS Survey.
Population Clinical
Consumer Use
Gallus (2023)
Changes in Availability of ENDS: 2019-2020, U.S.
Population Clinical
Consumer Use
Factors Influencing Patterns Of Use
Gammon (2022)
adverse effects of electronic cigarettes on the disease-naive oral microbiome.
Individual Clinical
Safety
Adverse Effects
Ganesan (2020)
addressing the challenges of E-cigarette safety profiling by assessment of pulmonary toxicological response in bronchial and alveolar mucosa models.
Nonclinical
Cardiovascular Toxicity
In Vitro
Ganguly (2020)